Experience with endralazine in the treatment of essential hypertension
Dvorák, I.; Dvorák, M.; Blaha, M.; Kubesová, H.; Havlát, F.; Nĕmcová, H.
Vnitrni Lekarstvi 30(1): 42-47
1984
ISSN/ISBN: 0042-773X PMID: 6364562 Document Number: 232806
Document emailed within 1 workday
Related Documents
Fet'kovská, N.; Tison, P. 1984: Endralazine in the treatment of hypertension Vnitrni Lekarstvi 30(2): 163-168Seedat, Y.K.; Rawat, R. 1984: A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension South African Medical Journal 66(18): 682-684
Elliott, H.L.; Meredith, P.A.; Howden, C.W.; Lawrie, C.B.; Reid, J.L. 1984: Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensives International Journal of Clinical Pharmacology Research 4(1): 61-69
Brunner, H.R.; Waeber, B.; Nussberger, J.; Schaller, M.D.; Gomez, H.J. 1983: Long-term clinical experience with enalapril in essential hypertension Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 1(1): 103-107
Stott, D.J.; Ball, S.G. 1986: Treatment of essential hypertension British Journal of Hospital Medicine 36(4): 261
Gerc, V.; Numić, N. 1984: Modern treatment of essential hypertension Medicinski Arhiv 38(5): 233-238
Minushkina, L.O.; Sidorenko, B.A. 2003: Metoprolol in the treatment of essential hypertension Kardiologiia 43(11): 102-105
Salgueiro Rodríguez, M.; Pérez Pombo, S.; Beiras García, E. 1981: Metoprolol in the treatment of essential hypertension Medicina Clinica 76(3): 121-124
Sharma, P.L.; Pandhi, P. 1985: Progress in the treatment of essential hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 23 Suppl. 1: S54-S61
Kakhnovskiĭ, I.M.; Sivkov, S.I.; Gavrilova, E.N.; Belaia, O.L.; Sivkov, A.S.; Markova, Z.S.; Markov, I.E.; Gaĭdamakina, N.E. 1998: Prestarium treatment of essential hypertension Klinicheskaia Meditsina 76(9): 52-54
Dosh, S.A. 2002: The treatment of adults with essential hypertension Journal of Family Practice 51(1): 74-80
Milei, J.; Lemus, J.; Bernardiner, E. 1986: Ketanserin in the treatment of essential hypertension. a double-blind study against metoprolol and a further long-term open treatment Acta Cardiologica 41(6): 427-441
Staessen, J.; Fagard, R.; Fiocchi, R.; Lijnen, P.; M'Buyamba-Kabangu, J.R.; Amery, A. 1986: Chronic treatment with tibalosine in essential hypertension Archives Internationales de Pharmacodynamie et de Therapie 279(1): 162-176
Kennedy, S. 2006: Essential hypertension 2: treatment and monitoring update Community Practitioner: the Journal of the Community Practitioners' and Health Visitors' Association 79(2): 64-66
Ghiuru, R.; Rezuş, C.; Ambăruş, V.; Ionescu, S.; Cosovanu, A. 2001: Nebivolol treatment in essential arterial hypertension Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 105(4): 756-759
Pérez-Grovas, H.; Fernández, M.; Arriaga, J.; Herrera-Acosta, J. 1986: Enalapril in the treatment of essential arterial hypertension Archivos del Instituto de Cardiologia de Mexico 56(5): 379-390
Paladini, G.; Sgoifo, E. 1980: Dioodobufenine in the treatment of essential arterial hypertension Minerva Cardioangiologica 28(5): 303-308
Garnier, L.F. 1988: Essential arterial hypertension. from notion to treatment Annales de Cardiologie et d'Angeiologie 37(7): 371-380
Paris, J.V.; González, C.A. 1991: Nicardipine and nifedipine in the treatment of essential arterial hypertension Proceedings of the Western Pharmacology Society 34: 303-309
Bühler, R.; Laragh, J.H. 1973: Essential hypertension: biochemical analysis--selective treatment Schweizerische Rundschau für Medizin Praxis 62(16): 489-491